Effect of hip muscle strengthening in patients with Osteoarthritis of the knee.
- Conditions
- OsteoarthritisC05.550.114.606
- Registration Number
- RBR-5g9n5g
- Lead Sponsor
- niversidade São Judas Tadeu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Healthy volunteers; both genders; age between 50 and 90 years; present a medical report or radiographic evidence of OA according to the Kellgren and Lawrence scale; knee pain over the last week, be physically independent.
To present pathologies in incapacitating levels; having a diagnosis of fibromyalgia or rheumatoid arthritis; use of corticosteroid or intra-articular hyaluronic acid in the last 12 months; oral use of anti-inflammatory drugs last 2 months; participation in a neuromuscular strengthening or exercise program or other (non-pharmacological) treatment for knee OA in the last six months; prosthesis or any other surgery on the hip and knee joints; decompensated heart diseases; hearing or visual impairment. Participants were asked to refrain from seeking other forms of treatment during the exercise protocol.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Outcome 1: Significant regression (p = 0.001) of 35mm of pain levels by Visual Analogue Scale (0-100mm) after treatment termination.;Expected outcome 2: Significant regression (p <= 0.05) Western Ontario McMaster Universities scale after treatment termination.;Outcome found 2: Significant regression (p <= 0.005) 3.5 points of scale of Western Ontario McMaster Universities after termination of treatment.;Expected outcome 3: Significant regression (p <= 0.05) on the Mcgill Pain Questionnaire after treatment termination.;Outcome found 3: Significant regression (p <= 0.05) of 3.5 points on the Mcgill Pain Questionnaire after termination of treatment.;Expected outcome 1: Significant regression (p <= 0.05) of pain levels using Visual Analogue Scale parameters (0-100 mm) after treatment termination.
- Secondary Outcome Measures
Name Time Method Secondary outcomes are not expected.